Assertio Holdings, Inc.
General ticker "ASRT" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $84.0M (TTM average)
Assertio Holdings, Inc. follows the US Stock Market performance with the rate: 15.9%.
Estimated limits based on current volatility of 0.0%: low 23.50$, high 23.50$
Factors to consider:
- Total employees count: 58 (+9.4%) as of 2024
- Top business risk factors: Reimbursement risks, Product development failure, Insufficient capital, Integration challenges, Regulatory and compliance
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.67$, 1.54$]
- 2026-12-31 to 2027-12-31 estimated range: [0.61$, 1.42$]
Financial Metrics affecting the ASRT estimates:
- Positive: with PPE of -1.9 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0.12 <= 0.28
- Positive: 19.19 < Shareholder equity ratio, % of 35.19 <= 42.57
- Positive: Inventory ratio change, % of -6.58 <= -0.75
Short-term ASRT quotes
Long-term ASRT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $152.07MM | $124.96MM | $118.71MM |
| Operating Expenses | $395.61MM | $149.44MM | $140.25MM |
| Operating Income | $-243.54MM | $-24.48MM | $-21.54MM |
| Non-Operating Income | $-10.52MM | $2.95MM | $-8.40MM |
| Interest Expense | $13.30MM | $3.04MM | $3.08MM |
| R&D Expense | $2.84MM | $3.82MM | $1.69MM |
| Income(Loss) | $-254.05MM | $-21.53MM | $-29.94MM |
| Taxes | $77.89MM | $0.05MM | $0.43MM |
| Net Income(Loss)* | $-331.94MM | $-21.58MM | $-30.38MM |
| Stockholders Equity | $138.00MM | $121.08MM | $93.95MM |
| Inventory | $37.69MM | $38.31MM | $24.12MM |
| Assets | $286.42MM | $284.73MM | $266.97MM |
| Operating Cash Flow | $49.60MM | $26.41MM | $-28.18MM |
| Capital expenditure | $0.63MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $3.10MM | $-48.91MM | $-11.99MM |
| Financing Cash Flow | $-44.20MM | $-0.35MM | $-0.19MM |
| Earnings Per Share** | $-70.10 | $-3.40 | $-4.74 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.